VTv Current Assets vs Debt Current Analysis

VTVT Stock  USD 23.80  0.71  3.07%   
Trend analysis of VTv Therapeutics balance sheet accounts such as Total Assets of 10.5 M, Short Long Term Debt Total of 502.6 K, Other Current Liabilities of 5.9 M or Total Current Liabilities of 15 M provides information on VTv Therapeutics' total assets, liabilities, and equity, which is the actual value of VTv Therapeutics to its prevalent stockholders. By breaking down trends over time using VTv Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

About VTv Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of VTv Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. VTv Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of VTv Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which VTv currently owns. An asset can also be divided into two categories, current and non-current.

VTv Therapeutics Balance Sheet Chart

VTv Therapeutics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how VTv Therapeutics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, VTv Therapeutics' Property Plant And Equipment Gross is comparatively stable compared to the past year. Total Current Assets is likely to gain to about 16.9 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 5.9 M in 2024.

Total Assets

Total assets refers to the total amount of VTv Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in VTv Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on VTv Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of VTv Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from VTv Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into VTv Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.Issuance Of Capital Stock is likely to gain to about 16.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 11.5 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses25.7M24.6M25.4M26.4M
Cost Of Revenue89K92K90K85.5K

VTv Therapeutics fundamental ratios Correlations

-0.230.17-0.270.23-0.25-0.28-0.02-0.670.460.350.96-0.34-0.04-0.11-0.180.960.31-0.22-0.32-0.02-0.440.15-0.12-0.08-0.3
-0.23-0.640.96-0.79-0.360.97-0.060.86-0.34-0.27-0.340.810.8-0.78-0.19-0.34-0.280.18-0.150.620.06-0.28-0.830.780.96
0.17-0.64-0.530.63-0.03-0.740.51-0.540.440.780.21-0.52-0.430.580.10.210.5-0.280.02-0.56-0.030.110.63-0.62-0.74
-0.270.96-0.53-0.61-0.480.9-0.110.86-0.15-0.21-0.370.730.67-0.63-0.39-0.37-0.250.15-0.160.390.13-0.15-0.70.580.91
0.23-0.790.63-0.61-0.1-0.83-0.18-0.710.770.320.33-0.75-0.810.77-0.420.320.26-0.160.12-0.960.070.560.85-0.99-0.82
-0.25-0.36-0.03-0.48-0.1-0.230.13-0.14-0.64-0.47-0.2-0.27-0.260.360.72-0.20.16-0.11-0.120.19-0.440.010.240.06-0.18
-0.280.97-0.740.9-0.83-0.23-0.180.87-0.47-0.44-0.390.840.72-0.73-0.1-0.39-0.340.32-0.250.670.02-0.22-0.80.810.99
-0.02-0.060.51-0.11-0.180.13-0.180.01-0.210.58-0.090.060.28-0.020.48-0.090.33-0.260.160.230.09-0.42-0.060.18-0.19
-0.670.86-0.540.86-0.71-0.140.870.01-0.5-0.37-0.770.820.61-0.51-0.04-0.77-0.270.320.030.480.27-0.23-0.540.620.87
0.46-0.340.44-0.150.77-0.64-0.47-0.21-0.50.50.5-0.47-0.330.24-0.750.50.2-0.20.13-0.770.150.380.39-0.71-0.48
0.35-0.270.78-0.210.32-0.47-0.440.58-0.370.50.36-0.260.050.04-0.010.360.29-0.340.16-0.250.18-0.290.13-0.27-0.47
0.96-0.340.21-0.370.33-0.2-0.39-0.09-0.770.50.36-0.53-0.13-0.02-0.161.00.18-0.39-0.28-0.11-0.450.07-0.05-0.19-0.39
-0.340.81-0.520.73-0.75-0.270.840.060.82-0.47-0.26-0.530.61-0.610.03-0.53-0.20.66-0.040.610.29-0.11-0.60.720.8
-0.040.8-0.430.67-0.81-0.260.720.280.61-0.330.05-0.130.61-0.930.14-0.13-0.18-0.110.020.750.0-0.63-0.880.820.71
-0.11-0.780.58-0.630.770.36-0.73-0.02-0.510.240.04-0.02-0.61-0.93-0.04-0.020.22-0.02-0.04-0.75-0.010.530.89-0.82-0.7
-0.18-0.190.1-0.39-0.420.72-0.10.48-0.04-0.75-0.01-0.160.030.14-0.04-0.160.13-0.040.010.56-0.24-0.45-0.060.4-0.1
0.96-0.340.21-0.370.32-0.2-0.39-0.09-0.770.50.361.0-0.53-0.13-0.02-0.160.18-0.39-0.28-0.11-0.450.07-0.05-0.18-0.39
0.31-0.280.5-0.250.260.16-0.340.33-0.270.20.290.18-0.2-0.180.220.130.180.0-0.21-0.18-0.280.330.33-0.22-0.35
-0.220.18-0.280.15-0.16-0.110.32-0.260.32-0.2-0.34-0.390.66-0.11-0.02-0.04-0.390.0-0.050.110.320.470.070.140.25
-0.32-0.150.02-0.160.12-0.12-0.250.160.030.130.16-0.28-0.040.02-0.040.01-0.28-0.21-0.05-0.140.62-0.240.16-0.16-0.28
-0.020.62-0.560.39-0.960.190.670.230.48-0.77-0.25-0.110.610.75-0.750.56-0.11-0.180.11-0.14-0.18-0.58-0.810.980.65
-0.440.06-0.030.130.07-0.440.020.090.270.150.18-0.450.290.0-0.01-0.24-0.45-0.280.320.62-0.18-0.190.12-0.13-0.04
0.15-0.280.11-0.150.560.01-0.22-0.42-0.230.38-0.290.07-0.11-0.630.53-0.450.070.330.47-0.24-0.58-0.190.53-0.54-0.22
-0.12-0.830.63-0.70.850.24-0.8-0.06-0.540.390.13-0.05-0.6-0.880.89-0.06-0.050.330.070.16-0.810.120.53-0.88-0.8
-0.080.78-0.620.58-0.990.060.810.180.62-0.71-0.27-0.190.720.82-0.820.4-0.18-0.220.14-0.160.98-0.13-0.54-0.880.79
-0.30.96-0.740.91-0.82-0.180.99-0.190.87-0.48-0.47-0.390.80.71-0.7-0.1-0.39-0.350.25-0.280.65-0.04-0.22-0.80.79
Click cells to compare fundamentals

VTv Therapeutics Account Relationship Matchups

VTv Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets9.3M14.8M25.5M33.2M11.0M10.5M
Short Long Term Debt Total7.1M915K932K716K529K502.6K
Other Current Liab4.8M4.2M8.1M4.9M6.2M5.9M
Total Current Liabilities13.4M6.4M8.5M7.7M10.6M15.0M
Total Stockholder Equity(49.0M)(80.1M)(9.7M)(10.7M)(24.7M)(25.9M)
Other Liab3.9M3.9M1.3M19.4M17.4M18.3M
Property Plant And Equipment Net1.0M849K680K556K361K343.0K
Net Debt5.3M(4.8M)(12.5M)(11.4M)(8.9M)(8.5M)
Retained Earnings(233.5M)(290.0M)(248.8M)(265.5M)(281.0M)(295.1M)
Accounts Payable7.1M6.1M8.0M2.5M4.1M5.5M
Cash1.8M5.7M13.4M12.1M9.4M14.4M
Non Current Assets Total6.4M7.6M9.9M6.1M361K343.0K
Non Currrent Assets Other2.5M2.9M(7.6M)(6.1M)(5.5M)(5.3M)
Other Assets4.8M2.5M2.9M7.2M8.3M8.7M
Cash And Short Term Investments1.8M5.7M13.4M12.1M9.4M14.4M
Net Receivables5K158K57K12.4M102K96.9K
Common Stock Shares Outstanding12.4M30.3M47.1M60.7M2.1M2.0M
Short Term Investments250K371K100K15K17.3K16.4K
Liabilities And Stockholders Equity9.3M14.8M25.5M33.2M11.0M10.5M
Non Current Liabilities Total44.9M88.5M26.7M36.3M18.9M18.0M
Other Current Assets806K939K2.0M2.5M1.1M1.1M
Other Stockholder Equity183.9M209.2M238.2M253.7M256.3M163.5M
Total Liab58.3M94.9M35.2M44.0M29.6M28.1M
Property Plant And Equipment Gross1.0M367K680K556K848K1.1M
Total Current Assets2.8M7.2M15.6M27.1M10.7M16.9M
Short Term Debt6.3M239K440K378K360K342K
Property Plant Equipment1.0M367K680K207K186.3K177.0K
Net Tangible Assets(49.0M)3.8M(9.7M)5.8M6.7M7.1M
Short Long Term Debt6.2M84K256K224K191K181.5K
Common Stock Total Equity435K641K541K1.0M1.2M1.3M
Capital Surpluse150.6M183.9M209.2M253.7M291.8M183.4M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VTv Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VTv Therapeutics' short interest history, or implied volatility extrapolated from VTv Therapeutics options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether VTv Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if VTv Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Vtv Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Vtv Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for VTv Stock analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamental Analysis
View fundamental data based on most recent published financial statements
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is VTv Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.71)
Revenue Per Share
0.004
Return On Assets
(0.72)
Return On Equity
(49.78)
The market value of VTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.